Fate Therapeutics Inc.
FATE | NASDAQ
$2.60
+$0.07 (+2.77%)
Sep 22, 2026, 1:19 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.08M | 1.3M | 1.37M | 1.74M | 1.91M | 1.63M | 1.86M | 3.07M | 6.77M | 1.93M | 1.68M | 1.94M | 933K | 58.98M | 44.36M | 14.98M | 18.55M | 18.41M | 17.07M | 14.23M | 13.41M | 11.14M |
Cost of Revenue | n/a | 2.92M | n/a | 25.84M | 3.82M | 29.14M | 17.14M | 34.65M | 4.72M | 4.82M | 4.89M | 4.74M | 40.88M | 65.63M | 87.19M | 79.82M | 81.31M | 72.14M | 69.52M | 53.13M | 48.02M | 44.85M |
Gross Profit | 2.08M | -1.62M | 1.37M | -24.1M | -1.91M | -27.51M | -15.28M | -31.58M | 2.05M | -2.9M | -3.21M | -2.8M | -39.94M | -6.65M | -42.84M | -64.84M | -62.76M | -53.73M | -52.45M | -38.91M | -34.61M | -33.71M |
Operating Income | -31.13M | -33M | -34.72M | -34.74M | -36.97M | -41.28M | -61.75M | -52.38M | -45.08M | -51.07M | -48.08M | -51.28M | -62.57M | -28.59M | -64.42M | -86.39M | -83.11M | -74.47M | -69.38M | -54.62M | -46.78M | -46.21M |
Interest Income | 1.56M | 1.87M | 2.22M | 2.58M | 2.92M | 3.34M | 3.87M | 4.44M | 4.83M | 4.15M | 4.41M | 4.7M | 4.38M | 3.69M | 2.88M | 1.79M | 757K | 418K | 297K | 289K | 346K | 377K |
Pretax Income | -30.16M | -31.21M | -32.37M | -32.25M | -34.07M | -37.62M | -52.15M | -47.68M | -38.43M | -48M | -44.12M | -45.17M | -52.76M | -18.88M | -56.36M | -83.56M | -76.11M | -65.69M | -68.62M | -43.31M | -55.13M | -45.09M |
Net Income | -30.16M | -31.21M | -32.37M | -32.25M | -34.07M | -37.62M | -52.15M | -47.68M | -38.43M | -48M | -44.12M | -45.17M | -52.76M | -18.88M | -56.36M | -83.56M | -76.11M | -65.69M | -68.62M | -43.31M | -55.13M | -45.09M |
Selling & General & Admin | 8.83M | 9.6M | 10.67M | 10.64M | 11.45M | 13.77M | 31.73M | 20.8M | 17.25M | 20.86M | 17.94M | 18.95M | 22.62M | 21.94M | 21.58M | 21.56M | 20.35M | 20.74M | 16.94M | 15.72M | 12.17M | 12.5M |
Research & Development | 24.39M | 21.79M | 25.43M | 25.84M | 27.43M | 29.14M | 33.61M | 34.65M | 34.6M | 32.14M | 31.82M | 34.28M | 40.88M | 65.63M | 87.19M | 79.82M | 81.31M | 72.14M | 69.52M | 53.13M | 48.02M | 44.85M |
Other Expenses | n/a | n/a | n/a | -25.84M | -3.82M | -29.14M | -18.87M | -34.65M | -4.72M | -4.82M | -4.89M | -4.74M | -40.88M | -65.63M | -87.19M | -79.82M | -81.31M | -72.14M | -69.52M | -53.13M | -48.02M | -44.85M |
Operating Expenses | 33.22M | 31.38M | 36.09M | 10.64M | 35.05M | 13.77M | 46.47M | 20.8M | 47.13M | 48.17M | 44.87M | 48.48M | 22.62M | 21.94M | 21.58M | 21.56M | 20.35M | 20.74M | 16.94M | 15.72M | 12.17M | 12.5M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 16.47M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 33.22M | 34.3M | 36.09M | 36.48M | 38.88M | 42.91M | 63.61M | 55.45M | 51.86M | 52.99M | 49.75M | 53.22M | 63.5M | 87.57M | 108.78M | 101.37M | 101.66M | 92.88M | 86.45M | 68.85M | 60.19M | 57.35M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 120.4M | 120.03M | 118.79M | 119M | 118.53M | 118.38M | 117.79M | 117.77M | 117.47M | 101.1M | 98.61M | 98.57M | 98.4M | 98.05M | 97.22M | 97.02M | 96.7M | 96.34M | 95.79M | 95.41M | 94.33M | 93.43M |
Shares Outstanding (Diluted) | 120.4M | 120.03M | 118.79M | 119M | 118.53M | 118.38M | 117.79M | 117.77M | 117.47M | 101.1M | 98.61M | 98.57M | 98.4M | 98.05M | 97.22M | 97.02M | 96.7M | 96.34M | 95.79M | 95.41M | 94.33M | 93.43M |
EPS (Basic) | -0.25 | -0.26 | -0.27 | -0.27 | -0.29 | -0.32 | -0.44 | -0.40 | -0.33 | -0.47 | -0.45 | -0.46 | -0.54 | -0.09 | -0.50 | -0.83 | -0.79 | -0.59 | -0.72 | -0.45 | -0.58 | -0.48 |
EPS (Diluted) | -0.25 | -0.26 | -0.27 | -0.27 | -0.29 | -0.32 | -0.44 | -0.40 | -0.33 | -0.47 | -0.45 | -0.46 | -0.54 | -0.09 | -0.50 | -0.83 | -0.79 | -0.59 | -0.72 | -0.45 | -0.58 | -0.48 |
EBITDA | -30.55M | -28.3M | -29.31M | -29.02M | -30.79M | -34.29M | -42.2M | -43.07M | -33.71M | -43.18M | -39.24M | -40.43M | -48.29M | -14.69M | -51.52M | -80.37M | -73.14M | -62.93M | -66.42M | -41.79M | -53.97M | -45.25M |
EBIT | -30.55M | -31.21M | -32.37M | -32.25M | -34.07M | -37.62M | -47.01M | -47.68M | -38.43M | -48M | -44.12M | -45.17M | -52.76M | -18.88M | -56.36M | -83.56M | -76.11M | -65.69M | -68.62M | -43.31M | -55.13M | -46.21M |
Depreciation & Amortization | n/a | 2.92M | 3.06M | 3.23M | 3.28M | 3.33M | 4.81M | 4.61M | 4.72M | 4.82M | 4.89M | 4.74M | 4.47M | 4.19M | 4.84M | 3.19M | 2.96M | 2.76M | 2.21M | 1.52M | 1.17M | 959K |
Add to Watchlist
Select watchlists to add or remove FATE